Navigating Alzheimer's Research and Therapeutics

This chapter shares a poignant personal narrative about Alzheimer's disease, connecting the speaker's family history to the broader implications of genetic risk and therapeutic innovations. It explores the promising approach of partial reprogramming in Alzheimer's treatment, highlighting research advancements and the significant funding challenges faced by small biotech companies in pursuing human clinical trials. The discussion emphasizes the competitive landscape of gene therapy and the potential for diverse solutions in addressing aging and cognitive decline.